These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

17 related articles for article (PubMed ID: 6239027)

  • 1. Preformulation considerations for controlled release dosage forms. Part II. Selected candidate support.
    Chrzanowski F
    AAPS PharmSciTech; 2008; 9(2):639-45. PubMed ID: 18431656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effects of fenretinide metabolites N-[4-methoxyphenyl]retinamide (MPR) and 4-oxo-N-(4-hydroxyphenyl)retinamide (3-keto-HPR) on fenretinide molecular targets β-carotene oxygenase 1, stearoyl-CoA desaturase 1 and dihydroceramide Δ4-desaturase 1.
    Poliakov E; Samuel W; Duncan T; Gutierrez DB; Mata NL; Redmond TM
    PLoS One; 2017; 12(4):e0176487. PubMed ID: 28448568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liquid chromatography method for quantifying N-(4-hydroxyphenyl)retinamide and N-(4-methoxyphenyl)retinamide in tissues.
    Vratilova J; Frgala T; Maurer BJ; Patrick Reynolds C
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Sep; 808(2):125-30. PubMed ID: 15261805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of N-(4-hydroxyphenyl)-all-trans-retinamide in rats.
    Swanson BN; Zaharevitz DW; Sporn MB
    Drug Metab Dispos; 1980; 8(3):168-72. PubMed ID: 6104581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Putative metabolites derived from dietary combinations of calcium glucarate and N-(4-hydroxyphenyl)retinamide act synergistically to inhibit the induction of rat mammary tumors by 7,12-dimethylbenz[a]anthracene.
    Abou-Issa HM; Duruibe VA; Minton JP; Larroya S; Dwivedi C; Webb TE
    Proc Natl Acad Sci U S A; 1988 Jun; 85(12):4181-4. PubMed ID: 2967969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of primary prostate cancer in Lobund-Wistar rats by N-(4-hydroxyphenyl)retinamide.
    Pollard M; Luckert PH; Sporn MB
    Cancer Res; 1991 Jul; 51(13):3610-1. PubMed ID: 1829024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of N-(4-hydroxyphenyl)retinamide polymorphic forms by X-ray powder diffraction.
    Chrzanowski FA; Fegely BJ; Sisco WR; Newton MP
    J Pharm Sci; 1984 Oct; 73(10):1448-50. PubMed ID: 6239027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioactivities of N-(4-hydroxyphenyl) retinamide and retinoyl beta-glucuronide.
    Formelli F; Barua AB; Olson JA
    FASEB J; 1996 Jul; 10(9):1014-24. PubMed ID: 8801162
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.